Intrapericardial and Intrapleural Administration of Rituximab to a Patient with Marginal Zone Lymphoma

Publisher： Karger

E-ISSN： 1421-9662|130|3|169-171

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.3, 2013-05, pp. : 169-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab for Treatment of Advanced Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Lymphoma

By  

Oncology, Vol. 65, Iss. 4, 2004-01 ,pp. : 306-310

Karger

Access to resources Recommend Favorite

Development of Splenic Marginal Zone Lymphoma in a HIV-Negative Patient with Visceral Leishmaniasis

By  

Acta Haematologica, Vol. 128, Iss. 1, 2012-05 ,pp. : 20-22

Karger

Access to resources Recommend Favorite

« Malignant » Rosacea as a sign of systemic marginal zone lymphoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 2, 2018-02 ,pp. : e71-e72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B‐cell lymphoma and primary cutaneous Rosai–Dorfman disease in the same patient

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e355-e355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rethinking primary cutaneous marginal zone lymphoma: shifting the focus to the cause of the infiltrate

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 303-6987, Iss. 9, 2015-09 ,pp. : 600-603

John Wiley & Sons Inc

Access to resources Recommend Favorite